Cacna1g has also been identified as a genetic modifier of epilepsy in the Scn1a+/− mouse model of Dravet syndrome (Calhoun et al., 2017). The gene discussed is CACNA1G; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.